STAAR Surgical Company STAA Stock
STAAR Surgical Company Price Chart
STAAR Surgical Company STAA Financial and Trading Overview
| STAAR Surgical Company stock price | 26.07 USD |
| Previous Close | 50.48 USD |
| Open | 50.02 USD |
| Bid | 0 USD x 1000 |
| Ask | 0 USD x 800 |
| Day's Range | 49.65 - 52.79 USD |
| 52 Week Range | 46.36 - 112.27 USD |
| Volume | 644.81K USD |
| Avg. Volume | 618.84K USD |
| Market Cap | 2.55B USD |
| Beta (5Y Monthly) | 1.179577 |
| PE Ratio (TTM) | 84.95161 |
| EPS (TTM) | -1.96 USD |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | 78.22 USD |
STAA Valuation Measures
| Enterprise Value | 2.27B USD |
| Trailing P/E | 84.95161 |
| Forward P/E | 47.881817 |
| PEG Ratio (5 yr expected) | 3.06 |
| Price/Sales (ttm) | 8.637752 |
| Price/Book (mrq) | 7.510338 |
| Enterprise Value/Revenue | 7.695 |
| Enterprise Value/EBITDA | 57.6 |
Trading Information
STAAR Surgical Company Stock Price History
| Beta (5Y Monthly) | 1.179577 |
| 52-Week Change | -16.93% |
| S&P500 52-Week Change | 20.43% |
| 52 Week High | 112.27 USD |
| 52 Week Low | 46.36 USD |
| 50-Day Moving Average | 62.71 USD |
| 200-Day Moving Average | 66.1 USD |
STAA Share Statistics
| Avg. Volume (3 month) | 618.84K USD |
| Avg. Daily Volume (10-Days) | 1.06M USD |
| Shares Outstanding | 48.33M |
| Float | 39.2M |
| Short Ratio | 10.11 |
| % Held by Insiders | 0.72% |
| % Held by Institutions | 101.89% |
| Shares Short | 6.3M |
| Short % of Float | 27.26% |
| Short % of Shares Outstanding | 13.02% |
Dividends & Splits
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0% |
| 5 Year Average Dividend Yield | N/A |
| Payout Ratio | 0 |
| Last Split Factor | 1:2 |
Financial Highlights
Fiscal Year
| Fiscal Year Ends | December 30, 2022 |
| Most Recent Quarter (mrq) | March 31, 2023 |
| Next Fiscal Year End | December 30, 2023 |
Profitability
| Profit Margin | 10.81% |
| Operating Margin (ttm) | 11.77% |
| Gross Margin | 78.61% |
| EBITDA Margin | 13.35% |
Management Effectiveness
| Return on Assets (ttm) | 5.63% |
| Return on Equity (ttm) | 10.35% |
Income Statement
| Revenue (ttm) | 294.72M USD |
| Revenue Per Share (ttm) | 6.13 USD |
| Quarterly Revenue Growth (yoy) | 16.30% |
| Gross Profit (ttm) | 223.38M USD |
| EBITDA | 39.37M USD |
| Net Income Avi to Common (ttm) | 31.86M USD |
| Diluted EPS (ttm) | 0.62 |
| Quarterly Earnings Growth (yoy) | -71.79% |
Balance Sheet
| Total Cash (mrq) | 203.85M USD |
| Total Cash Per Share (mrq) | 4.22 USD |
| Total Debt (mrq) | 31.91M USD |
| Total Debt/Equity (mrq) | 9.41 USD |
| Current Ratio (mrq) | 6.648 |
| Book Value Per Share (mrq) | 7.013 |
Cash Flow Statement
| Operating Cash Flow (ttm) | 35.23M USD |
| Levered Free Cash Flow (ttm) | 8.17M USD |
Profile of STAAR Surgical Company
| Country | United States |
| State | CA |
| City | Lake Forest |
| Address | 25651 Atlantic Ocean Drive |
| ZIP | 92630 |
| Phone | 626 303 7902 |
| Website | https://www.staar.com |
| Industry | Medical Instruments & Supplies |
| Sector(s) | Healthcare |
| Full Time Employees | 882 |
STAAR Surgical Company, together with its subsidiaries, designs, develops, manufactures, markets, and sells implantable lenses for the eye, and companion delivery systems to deliver the lenses into the eye. The company provides Visian implantable Collamer lens product family (ICLs) to treat visual disorders, such as myopia, hyperopia, astigmatism, and presbyopia; and Hyperopic ICL, which treats far-sightedness. It also offers preloaded silicone cataract intraocular lenses and injector systems for use in cataract surgery. In addition, the company sells injector parts, and other related instruments and devices. It markets its products to health care providers, including ophthalmic surgeons, vision and surgical centers, hospitals, government facilities, and distributors, as well as products are primarily used by ophthalmologists. The company sells its products directly through its sales representatives in the United States, Japan, Germany, Spain, Canada, the United Kingdom, and Singapore, as well as through own representatives and independent distributors in China, Korea, India, France, Benelux, Italy, and internationally. STAAR Surgical Company was incorporated in 1982 and is headquartered in Lake Forest, California.
Q&A For STAAR Surgical Company Stock
What is a current STAA stock price?
STAAR Surgical Company STAA stock price today per share is 26.07 USD.
How to purchase STAAR Surgical Company stock?
You can buy STAA shares on the Tech Market Middle exchange. Contact your financial advisor to select a broker.
What is the ticker symbol for STAAR Surgical Company?
The stock symbol or ticker of STAAR Surgical Company is STAA.
Which industry does the STAAR Surgical Company company belong to?
The STAAR Surgical Company industry is Medical Instruments & Supplies.
How many shares does STAAR Surgical Company have in circulation?
The max supply of STAAR Surgical Company shares is 49.37M.
What is STAAR Surgical Company Price to Earnings Ratio (PE Ratio)?
STAAR Surgical Company PE Ratio is now.
What was STAAR Surgical Company earnings per share over the trailing 12 months (TTM)?
STAAR Surgical Company EPS is -1.96 USD over the trailing 12 months.
Which sector does the STAAR Surgical Company company belong to?
The STAAR Surgical Company sector is Healthcare.
STAAR Surgical Company STAA included in indexes
| Name Name | Price Price |
24h% 7d chart 24h% & 7d |
VOL Volume | 24h low | 24h high | Volume |
|---|
| Name Name | Price Price |
24h% 7d chart 24h% & 7d |
VOL Volume | 24h low | 24h high | Volume | |
|---|---|---|---|---|---|---|---|
| {{ item.name }} {{ item.symbol }} | {{ item.price }} {{ item.price_usd }} |
{{ item.change_pct }}
|
{{ item.volume }} {{ item.volume_usd }} | {{ item.low }} {{ item.low_usd }} | {{ item.high }} {{ item.high_usd }} | {{ item.components_count }} - | {{ item.volume }} {{ item.volume_usd }} |
| US Tech Composite IXIC | 23256.78 USD — |
-0.47
|
1.83B USD — | 23110.21 USD — | 23276.71 USD — | — - | 1.83B USD — |
| US Tech Composite Total Return XCMP | 28576.42 USD — |
-0.49
|
— — | 28402.23 USD — | 28597.12 USD — | — - | — — |
| US Tech AlphaDEX Multi Cap Growt NQDXUSMLTCG | 3445.4 USD — |
-0.89
|
— — | 3426.1 USD — | 3452.17 USD — | — - | — — |
| US Tech Health Care IXHC | 1195.31 USD — |
-1.28
|
— — | 1195.3 USD — | 1202.13 USD — | — - | — — |
| US Tech Global Market Composite NQGM | 2216.16 USD — |
-1.37
|
— — | 2210.09 USD — | 2222.36 USD — | — - | — — |
- {{ link.label }} {{link}}


